Patient Perspective: Cardiac Amyloidosis

Scripps Health

M. Nichols

The Role of SCT Amidst Emerging Therapies in the Treatment of AL Amy…

Rush University Medical Center

V. Sanchorawala

HFpEF or Amyloidosis? The Right Therapies for Right Patients

Scripps Health

M. Kittleson

Cardiac Amyloidosis: An Overlooked but Treatable Cause of HFpEF

Inova Heart and Vascular Institute - Advanced Heart Failure Symposium

SOHO 2022: Amyloidosis - Update and How To Use Novel Agents

SOHO 2022 Tenth Annual Meeting

S. Lentzsch

Amyloidosis Types and Pathophysiology

Houston Methodist

B. Trachtenberg

Cardiac Amyloidosis: A New Era of Diagnostics and Therapeutics

UCLA Health

D. Vucicevic

Amyloidosis: Diagnosis, Risk Stratification, and Treatment

Indy Hematology Review

M. Gertz

Diagnostic and Treatment Strategies for AL Amyloidosis in an Era of …

Cleveland Clinic Taussig Cancer Institute

F. Anwer

Experts Discuss the Management of Monoclonal Gammopathy of Renal Sig…

MyCancerHaven

R. Vij, N. Leung

Emerging Therapies in Cardiac Amyloidosis

NYU Langone

M. Hanna

Amyloidosis Background: Soft Tissue and GI/Liver AL Amyloid

Yale Cancer Center

S. Browning

Amyloidosis, Other Infiltrative Heart Disease, and What You Need to …

NYU Langone

A. Reyentovich

New Diagnostic and Treatment Strategies in Cardiac Amyloidosis

Canadian Collaborative Research Network

M. Davis

Understanding AL Amyloidosis: Clinical Syndromes and Biological Impl…

Houston Methodist

V. Sanchorawala

Treatment of ATTR-CM: New Drugs on the Horizon

Scripps Health

J. Rosenthal

Therapies for Pulmonary Venous Hypertension: Updates on the Treatmen…

Scripps Health

R. Mohan

Cardiac Amyloidosis: Evaluation and New Therapies

Cleveland Clinic Heart, Vascular and Thoracic Institute

M. Hanna

Amyloidosis 101: Biology, Diagnosis and Treatment Approaches

MyCancerHaven

R. Vij, K. Stockerl-Goldstein

Overview of Cardiac Amyloidosis

Yale Cancer Center

E. Miller